loading

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.63%
34.75
33.86 29.45 25.34 25.70
Operating Income/Loss
2.63%
-34.75
-33.86 -29.45 -25.34 -25.70
Income/Loss From Continuing Operations Before Tax
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Income/Loss From Continuing Operations After Tax
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Net Income/Loss
5.37%
-28.52
-30.14 -25.71 -21.47 -22.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24,620%
87.57
0.3542 63.46 63.38 63.27
Diluted Average Shares
24,620%
87.57
0.3542 63.46 63.38 63.27
Basic Earnings Per Share
29.79%
-0.33
-0.47 -0.41 -0.34 -0.36
Diluted Earnings Per Share
29.79%
-0.33
-0.47 -0.41 -0.34 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):